Evolutionary Genomics, Inc. Debt Securities, Trading, and Equity Securities, FV-NI
Evolutionary Genomics, Inc. had Debt Securities, Trading, and Equity Securities, FV-NI of $290.71 thousand as of 2017-12-31, per its 10-K filed 2018-03-05.
Discontinued › Notes › Investments
us-gaap:TradingSecurities · last filed 2018-03-05
- 2017-12-31: Debt Securities, Trading, and Equity Securities, FV-NI $290.71K.
- 2017-09-30: Debt Securities, Trading, and Equity Securities, FV-NI $545.82K.
- 2017-06-30: Debt Securities, Trading, and Equity Securities, FV-NI $1.29M.
- 2017-03-31: Debt Securities, Trading, and Equity Securities, FV-NI $1.56M.
| Period end | Debt Securities, Trading, and Equity Securities, FV-NI |
|---|---|
| 2017-12-31 | $290.71K 10-K · filed 2018-03-05 |
| 2017-09-30 | $545.82K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $1.29M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $1.56M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $64.30K 10-K · filed 2018-03-05 |
| 2016-09-30 | $1.32M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $2.06M 10-Q · filed 2016-08-12 |
| 2016-03-31 | $2.43M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $257.70K 10-K · filed 2017-02-10 |
| 2014-12-31 | $269.69K 10-K · filed 2016-02-19 |